Taiwan Semiconductor
TSM
ASML Holding
ASML
Advanced Micro Devices
AMD
Tesla
TSLA
Meta Platforms
META
US Stock MarketDetailed Quotes
CRSP CRISPR Therapeutics
- 55.150
- +3.980+7.78%
Close Dec 2 16:00 ET
- 55.400
- +0.250+0.45%
Pre 05:37 ET
4.71BMarket Cap-19767P/E (TTM)
55.500High50.970Low3.66MVolume51.120Open51.170Pre Close197.25MTurnover4.36%Turnover RatioLossP/E (Static)85.35MShares91.10052wk High2.43P/B4.63BFloat Cap43.42052wk Low--Dividend TTM83.93MShs Float220.200Historical High--Div YieldTTM8.85%Amplitude11.630Historical Low53.962Avg Price1Lot Size
CRISPR Therapeutics Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -168.25%-106.91M | 28.27%-95.58M | 1,147.32%109.75M | 47.48%-260.38M | 15.23%-96.07M | 62.12%-39.86M | 6.14%-133.25M | 106.51%8.8M | -191.98%-495.74M | -31.72%-113.33M |
| Net income from continuing operations | 23.37%-85.94M | -62.60%-126.41M | -119.71%-116.59M | 76.37%-153.61M | 180.80%89.35M | 35.75%-112.15M | 58.17%-77.74M | 70.39%-53.07M | -272.16%-650.18M | 21.72%-110.58M |
| Depreciation and amortization | -3.78%4.74M | -2.34%4.85M | -4.32%4.83M | -17.93%19.84M | -16.18%4.9M | -1.85%4.93M | -31.75%4.96M | -16.36%5.05M | 34.64%24.17M | -6.63%5.85M |
| Other non cash items | -33.69%-6.9M | -159.63%-8.18M | -765.33%-8.39M | -212.63%-14.05M | -2,276.26%-4.77M | -299.96%-5.16M | -188.21%-3.15M | -115.89%-969K | -11.62%12.47M | -95.33%219K |
| Change In working capital | -176.78%-40.36M | 113.27%10.49M | 470.33%210.49M | -1,075.49%-193.59M | -545.02%-203.97M | 41.34%52.56M | -1,066.16%-79.08M | 505.53%36.91M | -26.11%19.85M | -271.01%-31.62M |
| -Change in receivables | --0 | --0 | --200M | -65,673.77%-200M | -408,263.27%-200M | 411,664.71%70M | -91,009.09%-70M | --0 | 289.44%305K | 132.03%49K |
| -Change in prepaid assets | -123.01%-188K | -39.98%2.35M | -75.51%2.95M | 1,353.00%23.22M | 218.05%6.45M | -83.76%817K | 251.69%3.91M | 161.11%12.04M | 111.49%1.6M | -212.36%-5.46M |
| -Change in payables and accrued expense | -54.53%-38.16M | 180.17%9.28M | -62.55%9.44M | -492.08%-20.25M | 70.44%-9.19M | -188.32%-24.69M | -216.72%-11.58M | 1,660.27%25.21M | -86.23%5.16M | -236.50%-31.1M |
| -Change in other current liabilities | 128.18%31K | 112.70%40K | -154.12%-432K | 107.23%110K | 7.80%705K | 89.29%-110K | 68.31%-315K | -10.39%-170K | 71.33%-1.52M | -44.48%654K |
| -Change in other working capital | -131.19%-2.04M | -7.18%-1.18M | -730.51%-1.47M | -76.69%3.33M | -145.76%-1.94M | 25.68%6.55M | -162.43%-1.1M | -105.72%-177K | 63.92%14.3M | 141.61%4.24M |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -168.25%-106.91M | 28.27%-95.58M | 1,147.32%109.75M | 47.48%-260.38M | 15.23%-96.07M | 62.12%-39.86M | 6.14%-133.25M | 106.51%8.8M | -191.98%-495.74M | -31.72%-113.33M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -233.17%-161.6M | -158.50%-126.91M | -183.00%-97.8M | 244.84%374.65M | 53.60%-81.45M | 38.74%121.35M | 486.87%216.92M | 202.89%117.83M | 75.02%-258.66M | -1,913.91%-175.53M |
| Net PPE purchase and sale | 89.66%-219K | 80.11%-707K | 76.43%-721K | 74.53%-9.47M | 88.08%-738K | 64.80%-2.12M | 63.08%-3.56M | 80.07%-3.06M | 54.49%-37.19M | 32.58%-6.19M |
| Net intangibles purchase and sale | --0 | ---- | ---- | ---2.5M | --0 | ---1M | ---- | ---- | --0 | --0 |
| Net investment purchase and sale | -229.66%-161.39M | -156.85%-126.2M | -180.30%-97.08M | 274.57%386.62M | 52.34%-80.72M | 33.15%124.47M | 577.97%221.98M | 221.91%120.89M | 76.78%-221.47M | -36,361.46%-169.34M |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -233.17%-161.6M | -158.50%-126.91M | -183.00%-97.8M | 244.84%374.65M | 53.60%-81.45M | 38.74%121.35M | 486.87%216.92M | 202.89%117.83M | 75.02%-258.66M | -1,913.91%-175.53M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 519.54%9.64M | -102.78%-466K | 5,561.25%305.93M | 62.38%62.66M | 1,471.39%38.94M | -89.70%1.56M | 61.93%16.77M | -49.25%5.4M | -84.62%38.59M | -60.66%2.48M |
| Net common stock issuance | --6M | ---1.01M | --280.75M | 3,273.30%32.72M | --32.72M | --0 | --0 | --0 | -99.55%970K | --0 |
| Proceeds from stock option exercised by employees | 133.74%3.64M | -96.74%546K | 366.12%25.19M | -20.41%29.94M | 150.93%6.22M | -89.00%1.56M | 61.93%16.77M | -49.25%5.4M | -0.15%37.62M | -60.66%2.48M |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 519.54%9.64M | -102.78%-466K | 5,561.25%305.93M | 62.38%62.66M | 1,471.39%38.94M | -89.70%1.56M | 61.93%16.77M | -49.25%5.4M | -84.62%38.59M | -60.66%2.48M |
| Net cash flow | ||||||||||
| Beginning cash position | 8.63%495.99M | 101.88%718.94M | 79.00%401.07M | -76.16%224.06M | 5.74%539.6M | -11.01%456.6M | -49.18%356.12M | -76.16%224.06M | -20.71%939.94M | -50.38%510.33M |
| Current changes in cash | -411.72%-258.88M | -321.97%-222.95M | 140.76%317.89M | 124.72%176.94M | 51.61%-138.59M | 3,243.38%83.05M | 153.52%100.44M | 155.22%132.03M | -191.55%-715.8M | -223.76%-286.38M |
| Effect of exchange rate changes | 256.25%75K | -92.86%2K | -134.38%-11K | 191.25%73K | -46.96%61K | 52.00%-48K | 141.18%28K | 218.52%32K | -627.27%-80K | 3,733.33%115K |
| End cash Position | -56.04%237.19M | 8.63%495.99M | 101.88%718.94M | 79.00%401.07M | 79.00%401.07M | 5.74%539.6M | -11.01%456.6M | -49.18%356.12M | -76.16%224.06M | -76.16%224.06M |
| Free cash flow | -149.29%-107.13M | 30.38%-96.29M | 1,799.49%109.03M | 48.90%-272.35M | 19.00%-96.81M | 61.37%-42.97M | 8.76%-138.3M | 103.81%5.74M | -216.55%-532.93M | -25.52%-119.52M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | -- | -- | -- | -- | -- | Unqualified Opinion | -- |
Trending US Stocks
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
